BONESUPPORT: Another turn in the CERAMENT V FDA process - Redeye

BONESUPPORT announced that the FDA has requested additional biocompatibility data for CERAMENT V, extending the deadline for the company's complete response to October. The regulatory path for CERAMENT V has already been lengthy, and today’s announcement adds another step to the process. We continue to forecast a potential approval by the end of Q4 2026 or during Q1 2027.

Länk till analysen i sin helhet: https://www.redeye.se/research/1182427/bonesupport-another-turn-in-the-cerament-v-fda-process?utm_source=finwire&utm_medium=RSS